These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22914541)
1. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review. Cuspidi C; Rescaldani M; Sala C; Negri F; Grassi G; Mancia G J Hypertens; 2012 Nov; 30(11):2066-73. PubMed ID: 22914541 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. Cuspidi C; Sala C; Negri F; Mancia G; Morganti A; J Hum Hypertens; 2012 Jun; 26(6):343-9. PubMed ID: 22113443 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice. van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888 [TBL] [Abstract][Full Text] [Related]
4. Masked hypertension and echocardiographic left ventricular hypertrophy: an updated overview. Cuspidi C; Negri F; Sala C; Mancia G Blood Press Monit; 2012 Feb; 17(1):8-13. PubMed ID: 22183044 [TBL] [Abstract][Full Text] [Related]
5. Right ventricular hypertrophy in systemic hypertension: an updated review of clinical studies. Cuspidi C; Sala C; Muiesan ML; De Luca N; Schillaci G; J Hypertens; 2013 May; 31(5):858-65. PubMed ID: 23449015 [TBL] [Abstract][Full Text] [Related]
7. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate]. Grabysa R; Cholewa M Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese. Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460 [TBL] [Abstract][Full Text] [Related]
9. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C; Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718 [TBL] [Abstract][Full Text] [Related]
10. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study]. González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J; Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880 [TBL] [Abstract][Full Text] [Related]
11. Resistant hypertension and left ventricular hypertrophy: an overview. Cuspidi C; Vaccarella A; Negri F; Sala C J Am Soc Hypertens; 2010; 4(6):319-24. PubMed ID: 21130978 [TBL] [Abstract][Full Text] [Related]
12. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study. Bruno G; Giunti S; Bargero G; Ferrero S; Pagano G; Perin PC Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population. Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700 [TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide. Lokhandwala Y; Damle A Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative). Oberman A; Prineas RJ; Larson JC; LaCroix A; Lasser NL Am J Cardiol; 2006 Feb; 97(4):512-9. PubMed ID: 16461048 [TBL] [Abstract][Full Text] [Related]
16. T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension. Assanelli D; Di Castelnuovo A; Rago L; Badilini F; Vinetti G; Gianfagna F; Salvetti M; Zito F; Donati MB; de Gaetano G; Iacoviello L; J Electrocardiol; 2013; 46(6):487-91. PubMed ID: 24011993 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension. Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of left ventricular hypertrophy. Vakili BA; Okin PM; Devereux RB Am Heart J; 2001 Mar; 141(3):334-41. PubMed ID: 11231428 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients. Kumpusalo E; Lappi J; Miettinen H; Takala J J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673 [TBL] [Abstract][Full Text] [Related]
20. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study]. Li Y; Zhao D; Liu J; Li CF; Guo W; Chen CH; Hao P; Sun JY; Qin LP; Wang W Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1037-42. PubMed ID: 19102921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]